Feed LQDA
LQ

Liquidia LQDA NASDAQ · Healthcare · United States

$56.63 +0.41% +$0.23

Summary

37 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 115% a year over the last 3 years.
  • It holds more cash than debt: $396.1M against $168.8M.
  • The share price is below the Bulios Fair Price.
  • Out of every 100 USD of revenue, 32 USD is left as free cash.

What to watch

  • The company made a loss over the last 12 months.
  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $56.63

By our assumptions the business is worth more than its shares cost today.

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 192% a year over 5 years. Over the last 3 years it grew by 115% a year.

Growth in detail

Does it make money?

Reasonably

Over the last 12 months it made a loss of $94.2M.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt. The debt score is low because of the debt-to-equity ratio.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $72.55 is 28% above today's price. 70% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

The company reports no revenue by region.

Product brings in 94% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy